Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients
Authors:
- 1 January 2016
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 452, 109-119
Abstract
No abstract availableKeywords
Funding Information
- Changzhou No.2 People's Hospital (U2012/01)
This publication has 37 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Monitoring of Plasma Cell-Free DNA in Predicting Postoperative Recurrence of Clear Cell Renal Cell CarcinomaUrologia Internationalis, 2013
- Quantification of Plasma Cell-Free DNA1in Predicting Therapeutic Efficacy of Sorafenib on Metastatic Clear Cell Renal Cell CarcinomaDisease Markers, 2013
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary ReviewEuropean Urology, 2011
- Serum cell‐free DNA in renal cell carcinomaCancer, 2011
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureClinica Chimica Acta, 2010
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewCancer Treatment Reviews, 2008
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- Cell-Free DNA in Human Blood PlasmaPancreas, 1998